Royal Bank of Canada’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-29,693
| Closed | -$9.4M | – | 7161 |
|
2023
Q4 | $9.4M | Buy |
29,693
+6,830
| +30% | +$2.16M | ﹤0.01% | 1509 |
|
2023
Q3 | $3.87M | Buy |
22,863
+11,862
| +108% | +$2.01M | ﹤0.01% | 1996 |
|
2023
Q2 | $2.39M | Sell |
11,001
-1,142
| -9% | -$248K | ﹤0.01% | 2375 |
|
2023
Q1 | $2.21M | Buy |
12,143
+486
| +4% | +$88.3K | ﹤0.01% | 2434 |
|
2022
Q4 | $2.29M | Buy |
11,657
+6,548
| +128% | +$1.29M | ﹤0.01% | 2436 |
|
2022
Q3 | $1.15M | Buy |
5,109
+4,892
| +2,254% | +$1.1M | ﹤0.01% | 2916 |
|
2022
Q2 | $28K | Sell |
217
-1,190
| -85% | -$154K | ﹤0.01% | 5502 |
|
2022
Q1 | $178K | Sell |
1,407
-3,666
| -72% | -$464K | ﹤0.01% | 4718 |
|
2021
Q4 | $665K | Buy |
5,073
+2,997
| +144% | +$393K | ﹤0.01% | 3744 |
|
2021
Q3 | $254K | Sell |
2,076
-1,748
| -46% | -$214K | ﹤0.01% | 4458 |
|
2021
Q2 | $436K | Buy |
3,824
+2,801
| +274% | +$319K | ﹤0.01% | 3962 |
|
2021
Q1 | $123K | Buy |
1,023
+853
| +502% | +$103K | ﹤0.01% | 4841 |
|
2020
Q4 | $17K | Buy |
+170
| New | +$17K | ﹤0.01% | 5595 |
|
2020
Q2 | – | Sell |
-48
| Closed | -$3K | – | 6402 |
|
2020
Q1 | $3K | Buy |
+48
| New | +$3K | ﹤0.01% | 5723 |
|